DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,504 filers reported holding DANAHER CORPORATION in Q4 2019. The put-call ratio across all filers is 1.66 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $19,763,000 | -10.5% | 142,788 | -0.8% | 0.42% | +11.7% |
| Q4 2019 | $22,091,000 | +12.7% | 143,931 | +6.1% | 0.38% | +1.1% |
| Q3 2019 | $19,595,000 | +8.4% | 135,673 | +7.3% | 0.37% | 0.0% |
| Q2 2019 | $18,077,000 | +18.3% | 126,482 | +9.3% | 0.37% | +8.1% |
| Q1 2019 | $15,280,000 | +38.3% | 115,739 | +8.0% | 0.34% | +21.1% |
| Q4 2018 | $11,047,000 | -4.3% | 107,127 | +0.9% | 0.28% | +67.1% |
| Q3 2018 | $11,542,000 | -3.7% | 106,219 | -12.5% | 0.17% | -33.3% |
| Q2 2018 | $11,985,000 | +5.0% | 121,458 | +4.2% | 0.26% | -1.2% |
| Q1 2018 | $11,416,000 | -44.3% | 116,596 | -47.2% | 0.26% | -0.8% |
| Q4 2017 | $20,490,000 | +16.0% | 220,754 | +7.2% | 0.26% | -0.8% |
| Q3 2017 | $17,664,000 | +106.1% | 205,930 | +102.8% | 0.26% | +0.8% |
| Q2 2017 | $8,570,000 | -0.3% | 101,550 | +1.0% | 0.26% | -1.9% |
| Q1 2017 | $8,600,000 | +64.9% | 100,549 | +50.1% | 0.26% | +44.8% |
| Q4 2016 | $5,214,000 | +64.6% | 66,983 | +65.8% | 0.18% | +63.4% |
| Q3 2016 | $3,167,000 | – | 40,397 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |